Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

ACSM3 Inhibitors

ACSM3 inhibitors belong to a specialized class of chemical compounds designed to interact with the enzyme Acyl-CoA synthetase medium-chain family member 3 (ACSM3). This enzyme plays a crucial role in the metabolism of fatty acids, a fundamental biochemical process that involves the conversion of fatty acids into their acyl-CoA derivatives. These derivatives are essential for various metabolic pathways, including lipid synthesis and degradation, signaling molecules production, and energy generation. ACSM3 inhibitors are developed through an intricate process of identifying molecules that can effectively bind to this enzyme and modulate its activity. The design and development of these inhibitors involve advanced computational modeling to predict the interaction between the inhibitor and the enzyme, followed by chemical synthesis of candidate molecules and rigorous biochemical assays to assess their efficacy in inhibiting ACSM3 activity.

The development process of ACSM3 inhibitors is marked by a meticulous exploration of the enzyme's structure and function. Researchers utilize techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy to gain detailed insights into the three-dimensional structure of ACSM3. This structural knowledge is pivotal for identifying the active sites of the enzyme where inhibitors can bind. The binding of these inhibitors to ACSM3 can modulate its activity by either competitively blocking the substrate's access to the active site or by allosterically altering the enzyme's conformation. To ensure the specificity and potency of ACSM3 inhibitors, a combination of high-throughput screening and structure-activity relationship (SAR) studies are employed. These approaches allow scientists to systematically test a large number of compounds for their ability to inhibit ACSM3 and to refine their chemical structures based on the observed activity. The ultimate goal is to develop molecules that exhibit high specificity towards ACSM3, minimizing off-target effects and maximizing the desired interaction with the enzyme.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Metformin

657-24-9sc-507370
10 mg
$79.00
2
(0)

Metformin activates AMP-activated protein kinase (AMPK), which in turn can inhibit acyl-CoA synthetase activity by altering cellular energy states, thus indirectly affecting ACSM3.

Fenofibrate

49562-28-9sc-204751
5 g
$41.00
9
(1)

Fenofibrate is a peroxisome proliferator-activated receptor (PPAR) alpha agonist, which can modulate fatty acid oxidation and may thus influence ACSM3 activity.

Nicotinamide riboside

1341-23-7sc-507345
10 mg
$411.00
(0)

Nicotinamide riboside enhances NAD+ biosynthesis, which is required for the function of sirtuins that regulate fatty acid metabolism, potentially altering ACSM3 activity.

Berberine

2086-83-1sc-507337
250 mg
$92.00
1
(0)

Berberine activates AMPK, similarly to Metformin, which could lead to a reduction in acyl-CoA synthetase activity and hence influence ACSM3 indirectly.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol is known to activate sirtuins, which can modulate fatty acid metabolism, possibly affecting ACSM3's role in this process.

α-Lipoic Acid

1077-28-7sc-202032
sc-202032A
sc-202032B
sc-202032C
sc-202032D
5 g
10 g
250 g
500 g
1 kg
$69.00
$122.00
$212.00
$380.00
$716.00
3
(1)

α-Lipoic Acid can influence mitochondrial function and fatty acid oxidation, processes in which ACSM3 is implicated, hence potentially affecting its activity.